Boston Financial Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $28M | Buy |
1,054,464
+263,314
| +33% | +$7.14M | 0.84% | 36 |
|
|
2024
Q3 | $22.9M | Sell |
791,150
-521,168
| -40% | -$15.2M | 0.68% | 50 |
|
|
2024
Q2 | $36.7M | Sell |
1,312,318
-4,328
| -0.3% | -$119K | 1.17% | 26 |
|
|
2024
Q1 | $36.5M | Sell |
1,316,646
-9,140
| -0.7% | -$254K | 1.16% | 26 |
|
|
2023
Q4 | $38.2M | Sell |
1,325,786
-11,533
| -0.9% | -$349K | 1.29% | 23 |
|
|
2023
Q3 | $44.4M | Sell |
1,337,319
-758
| -0.1% | -$26.8K | 1.66% | 16 |
|
|
2023
Q2 | $49.1M | Sell |
1,338,077
-9,011
| -0.7% | -$351K | 1.77% | 13 |
|
|
2023
Q1 | $55M | Buy |
1,347,088
+5,102
| +0.4% | +$220K | 2.15% | 9 |
|
|
2022
Q4 | $68.8M | Buy |
1,341,986
+1,306
| +0.1% | +$62.6K | 2.76% | 4 |
|
|
2022
Q3 | $58.7M | Sell |
1,340,680
-778
| -0.1% | -$37.8K | 2.55% | 6 |
|
|
2022
Q2 | $70.3M | Buy |
1,341,458
+5,165
| +0.4% | +$263K | 3.03% | 4 |
|
|
2022
Q1 | $69.2M | Buy |
1,336,293
+3,390
| +0.3% | +$176K | 2.63% | 5 |
|
|
2021
Q4 | $78.7M | Sell |
1,332,903
-5,725
| -0.4% | -$284K | 2.86% | 6 |
|
|
2021
Q3 | $57.6M | Buy |
1,338,628
+6,517
| +0.5% | +$289K | 2.34% | 8 |
|
|
2021
Q2 | $52.2M | Sell |
1,332,111
-1,711
| -0.1% | -$66.5K | 2.11% | 12 |
|
|
2021
Q1 | $48.3M | Sell |
1,333,822
-42,012
| -3% | -$1.49M | 2.12% | 12 |
|
|
2020
Q4 | $50.6M | Sell |
1,375,834
-180,939
| -12% | -$6.64M | 2.3% | 11 |
|
|
2020
Q3 | $54.2M | Sell |
1,556,773
-926
| -0.1% | -$32.5K | 2.64% | 7 |
|
|
2020
Q2 | $48.3M | Sell |
1,557,699
-5,579
| -0.4% | -$190K | 2.6% | 8 |
|
|
2020
Q1 | $48.4M | Sell |
1,563,278
-11,836
| -0.8% | -$403K | 3.11% | 4 |
|
|
2019
Q4 | $58.6M | Sell |
1,575,114
-23,998
| -2% | -$855K | 3.21% | 4 |
|
|
2019
Q3 | $54.5M | Sell |
1,599,112
-3,854
| -0.2% | -$140K | 3.1% | 3 |
|
|
2019
Q2 | $65.9M | Sell |
1,602,966
-20,868
| -1% | -$829K | 3.81% | 1 |
|
|
2019
Q1 | $65.4M | Sell |
1,623,834
-7,326
| -0.4% | -$293K | 3.98% | 1 |
|
|
2018
Q4 | $67.6M | Sell |
1,631,160
-29,042
| -2% | -$1.21M | 4.68% | 1 |
|
|
2018
Q3 | $69.4M | Buy |
1,660,202
+4,545
| +0.3% | +$175K | 4.1% | 1 |
|
|
2018
Q2 | $57M | Buy |
1,655,657
+2,835
| +0.2% | +$96.9K | 3.85% | 1 |
|
|
2018
Q1 | $55.7M | Sell |
1,652,822
-12,733
| -0.8% | -$438K | 3.8% | 1 |
|
|
2017
Q4 | $57.2M | Sell |
1,665,555
-7,651
| -0.5% | -$261K | 3.83% | 1 |
|
|
2017
Q3 | $56.7M | Sell |
1,673,206
-15,765
| -0.9% | -$507K | 4.03% | 1 |
|
|
2017
Q2 | $53.8M | Buy |
1,688,971
+107,643
| +7% | +$3.39M | 3.87% | 1 |
|
|
2017
Q1 | $51.3M | Buy |
1,581,328
+105,056
| +7% | +$3.31M | 3.82% | 1 |
|
|
2016
Q4 | $45.5M | Sell |
1,476,272
-146,499
| -9% | -$4.47M | 3.59% | 1 |
|
|
2016
Q3 | $52.1M | Buy |
1,622,771
+976
| +0.1% | +$32.6K | 4.25% | 1 |
|
|
2016
Q2 | $54.2M | Buy |
1,621,795
+7,568
| +0.5% | +$242K | 4.42% | 1 |
|
|
2016
Q1 | $45.4M | Sell |
1,614,227
-539,453
| -25% | -$15.4M | 6.82% | 1 |
|
|
2015
Q4 | $66M | Sell |
2,153,680
-18,562
| -0.9% | -$584K | 9.46% | 1 |
|
|
2015
Q3 | $64.7M | Buy |
2,172,242
+2,218
| +0.1% | +$71.1K | 9.17% | 1 |
|
|
2015
Q2 | $69M | Sell |
2,170,024
-8,808
| -0.4% | -$287K | 8.88% | 1 |
|
|
2015
Q1 | $71.9M | Buy |
2,178,832
+21,500
| +1% | +$684K | 9% | 1 |
|
|
2014
Q4 | $63.8M | Sell |
2,157,332
-42,166
| -2% | -$1.21M | 8.01% | 1 |
|
|
2014
Q3 | $61.7M | Sell |
2,199,498
-17,685
| -0.8% | -$496K | 8.09% | 1 |
|
|
2014
Q2 | $62.4M | Sell |
2,217,183
-59,695
| -3% | -$1.7M | 8.24% | 1 |
|
|
2014
Q1 | $69.4M | Buy |
2,276,878
+84,193
| +4% | +$2.51M | 9.29% | 1 |
|
|
2013
Q4 | $63.7M | Sell |
2,192,685
-232,430
| -10% | -$6.76M | 8.74% | 1 |
|
|
2013
Q3 | $66.1M | Buy |
2,425,115
+575
| +0% | +$15.6K | 9.93% | 1 |
|
|
2013
Q2 | $64.4M | Buy |
+2,424,540
| New | +$67M | 9.95% | 1 |
|
Other funds holding PFE
Boston Financial Management's PFE Position: Q4 2024 in Review
Boston Financial Management increased its Pfizer (PFE) stake by 33% in Q4 2024, buying an estimated $7.14M and bringing the position to 1,054,464 shares worth $28M. The position accounts for 0.84% of the portfolio, ranked #36.
Boston Financial Management first reported a position in PFE in Q2 2013 and has held it in 47 quarters since. The position peaked at $78.7M in Q4 2021. 2,996 funds tracked by Wall St. Rank hold PFE as of Q4 2024.
- Boston Financial Management held 1,054,464 shares of Pfizer worth $28M as of Q4 2024.
- Boston Financial Management bought 263,314 Pfizer shares in Q4 2024, an estimated $7.14M.
- Pfizer made up 0.84% of Boston Financial Management's portfolio in Q4 2024, its #36 holding.
- Boston Financial Management first reported a position in Pfizer in Q2 2013 and has held it in 47 quarters since.
- Boston Financial Management's Pfizer position peaked at $78.7M in Q4 2021.
- 2,996 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.
Based on Boston Financial Management's 13F filing for Q4 2024, filed 3 Feb 2025.